The global Hereditary Testing Market is experiencing strong momentum as healthcare systems increasingly adopt genetic screening technologies to support early diagnosis, personalized treatment planning, and preventive healthcare strategies. According to Polaris Market Research, the market was valued at USD 7.73 billion in 2024 and is projected to grow from USD 8.36 billion in 2025 to USD 17.13 billion by 2034, registering a CAGR of 8.3% during 2025–2034.

The growth in hereditary testing market size reflects increasing awareness regarding inherited diseases and the expanding role of genetic analysis across clinical decision-making. Hereditary testing enables identification of mutations in genes, chromosomes, or proteins that may contribute to inherited disorders, helping clinicians evaluate disease risk and guide treatment pathways.

Technological progress remains one of the strongest growth drivers. Advances in next-generation sequencing (NGS) continue improving testing speed, throughput, and accuracy while reducing barriers to broader adoption. These developments are enabling healthcare providers to offer more comprehensive genetic insights across diverse patient populations.

Another important factor supporting market expansion is the increasing emphasis on precision medicine. Healthcare providers are moving toward individualized care models that rely on genomic information to optimize diagnosis and treatment decisions. Hereditary testing has become an essential component of this transition, particularly in preventive care and long-term disease management.

By technology, molecular testing accounted for the largest market share in 2024 due to its high analytical accuracy and broad adoption across hereditary diagnostics. Molecular techniques continue gaining traction because of their ability to detect genetic variations with greater precision and support more targeted clinical decisions.

Sample collection trends are also evolving. The blood segment maintained the largest market share due to reliability and widespread clinical use, while saliva-based testing is anticipated to witness the fastest growth because of rising demand for non-invasive and home-based testing approaches.

Read More @ https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market

Artificial intelligence and bioinformatics integration are further strengthening market opportunities by improving genetic interpretation capabilities and enabling more efficient analysis workflows. These innovations continue expanding the practical applications of hereditary diagnostics.

Regionally, North America held the dominant market position in 2024 due to advanced healthcare infrastructure, supportive regulatory frameworks, and strong adoption of genetic technologies. Meanwhile, Asia Pacific is expected to emerge as the fastest-growing region supported by increasing healthcare investment and expanding access to testing services.

As awareness of inherited conditions continues to increase globally, hereditary testing is expected to become increasingly integrated into routine healthcare delivery and preventive medicine programs.

More Trending Latest Reports By Polaris Market Research:

Digital Video Advertising Market

Real Time Location Systems Market

AI Watermarking Market

Aortic Valve Replacement Devices Market

U.S. Astaxanthin Market

Fragment Analysis Market

Stem Cell Market

Aroma Chemicals Market

electric submersible pump for oil & gas market